jeudi 2 août 2018

Onco Actu du 2 août 2018

2.4 Etiologie - Portables, ondes e-m

Exposure to High-Frequency Electromagnetic Fields at Work Does Not Seem to Correlate with Higher Risk of Brain Tumours [ISGlobal]

Electromagnetic Fields at Work Show No Brain Tumor Risk [Science-Based Medicine]

4.12 Biopsies liquides

Guardant Silent on TMB Plans, but Study Adds Evidence for Immunotherapy Prediction in Blood [Genome Web]

4.9 Dép., diag. & prono. - Sein

Breast Cancer Screening Market, Global Analysis by Population, Screening Tests [Mammography, MRI, Ultrasound] & Countries [ReportsnReports]

5.1 Traitements - Pré-clinique

Novel Drug Cocktails Strengthen Targeted Cancer Therapies While Lessening Side Effects [Mount Sinai]

5.10 Traitements - Essais

How will a clinical trial called CHHiP affect the future of prostate radiotherapy? [Institute of Cancer Research]

5.12 Immunothérapies

Immunotherapy: How the Immune System Fights Cancer [NCI-YouTube]

5.12.2 Immunothérapies - CAR-T, thérapies cellulaires

CAR-T player Cell Medica names Kite’s European chief as CEO [FierceBiotech]

5.2 Pharma

FDA Grants Breakthrough Therapy Designation to Daiichi Sankyo’s FLT3 Inhibitor Quizartinib for Relapsed/Refractory FLT3-ITD AML [Daiichi-Sankyo]

5.2.1 Pharma - Partenariats

Novartis dispatches two more cancer drug castoffs to a partner in China [EndPoints]

Why we need to recognise the full spectrum of research commercialisation activities in academia [Institute of Cancer Research]

5.2.3 Pharma - économie

A slowing market—not new rivals—is hurting Pfizer's star cancer med Ibrance, executives say [FiercePharma]

5.3 Traitements - FDA, EMA, NICE...

EU drugs agency sees 30 percent staff losses, more cuts in Brexit move [Reuters]

6.1 Observation

Lung Cancer Mortality Rates Among Women Projected to Increase Worldwide By Over 40 Percent By 2030 [AACR]

6.11 Patients

Patients’ roles and rights in research [BMJ]

6.12 Ethique

Series of ethical stumbles tests NIH’s reliance on private sector for research funding [STAT]

6.4 Médico-éco

Childhood cancer survivors face ‘financial toxicity’ [Washington Post]

6.6 Publications

Plan to replicate 50 high-impact cancer papers shrinks to just 18 [Science]

6.7.2 Applis

Voluntis Announces The Launch Of Theraxium Oncology, An Innovative Digital Platform For Symptom Management [Voluntis]

6.9 Controverses

Court records show how a medical device ‘seeding trial’ disguised marketing as science [HealthNewsReviews]